BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Tarsa Therapeutics 



Philadelphia  Pennsylvania    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Tarsa Therapeutics Reels In $7 Million To Prepare For Filing NDA For Ostora 5/29/2014 7:26:05 AM
Tarsa Therapeutics Presents Meta-Analysis at ASBMR 2013 Showing Calcitonin Does Not Appear to be Associated With Increased Risk of Cancer 10/7/2013 6:57:36 AM
Tarsa Therapeutics Reports Positive Results From Phase II Trial of Its Oral Calcitonin in Prevention of Post-Menopausal Osteoporosis 10/16/2012 9:27:42 AM
Tarsa Therapeutics' Drug Successful in Prevention of Post-Menopausal Osteoporosis 10/16/2012 6:54:54 AM
Tarsa Therapeutics to Assist Therapicon in Its Challenge to CHMP's Recommendation to Limit Use of Calcitonin 10/12/2012 10:54:55 AM
Tarsa Therapeutics Signs Commercial Supply Agreement for its Ostora(TM) Oral Calcitonin Product With QS Pharma 3/21/2012 10:44:03 AM
Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin 3/16/2012 6:27:25 AM
Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA(TM) Oral Calcitonin 12/13/2011 11:11:52 AM
Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial 9/19/2011 10:48:27 AM
Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase 3 Osteoporosis Treatment Trial 9/19/2011 6:27:18 AM
12